Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is a chronic multisystem condition affecting millions globally. Despite its prevalence, therapeutic options […]
Anticoagulant Use in COVID-19 Patients: A Longitudinal Study From Zanjan, Iran
Vanoushe Azimi Pirsaraei • Manizhe Jozpanahi • et. al., DOI: 10.7759/cureus.66798 Abstract Background The mortality and morbidity of thrombotic events in patients with coronavirus disease 2019 (COVID-19) are increasing worldwide. The clinical impact of prophylactic […]
Idiopathic Retroperitoneal Hematoma Associated With Anticoagulation in a Patient With Moderate COVID-19 Pneumonia
Hikaru Murooka • Natsumi Yamamoto • Shiho Amano •, et. al. DOI: 10.7759/cureus.87395 Abstract We report a case of idiopathic retroperitoneal hematoma in an 82-year-old man with moderate COVID-19 pneumonia receiving prophylactic anticoagulation therapy. The patient […]
Blood clotting discovery opens “whole new chapter in vascular biology”
By Paul McClure Researchers have identified a previously unknown biological process that causes tissue and organ damage in conditions where oxygen is low, such as heart attacks and strokes. The study […]
A Unique Case of Unprovoked Pulmonary Venous Thrombosis in a Postpartum Female Following COVID-19 Infection
Jordan Lipschutz • Sophia H. Ji • Mohammad Q. Jafri • Ambica Nair • Brian Kerr, 2024, DOI: 10.7759/cureus.64893 Abstract SARS-CoV-2 can induce a hypercoagulable state, occasionally resulting in pulmonary venous thrombosis (PVT) due to inflammation and endothelial injury. […]
Superior Mesenteric Artery Thrombosis Following Severe COVID-19 Pneumonia
Authors: Abdulhadi A Alali,1Mohammed O Baqais,2Fayez M Albishi,3, et. al. Cureus. (11):19954. doi: 10.7759/cureus.19954PMCID: PMC8713302PMID: 34976537 Abstract Thrombotic events are well-recognized complications of coronavirus disease 2019 (COVID-19). The incidence of such complications is highly related […]
Treatment of Long COVID symptoms with triple anticoagulant therapy
Gert J Laubscher, M Asad Khan, Chantelle Venter, Jan H Pretorius, and 2 more, This is a preprint; it has not been peer reviewed by a journal. https://doi.org/10.21203/rs.3.rs-2697680/v1 Research Square […]
UK scientists find link between proteins related to blood clots and long Covid
Biomarker discovery indicates that sufferers from brain fog and fatigue post-virus could be treated with anticoagulants Oksana Pyzik 31 Aug 2023 The Guardian Scientists have identified molecular signatures in the […]
COVID-19 vaccines and thrombosis with thrombocytopenia syndrome
Authors: Chih-Cheng Lai 1, Wen-Chien Ko 2, Chih-Jung Chen 3, Po-Yen Chen 4, Yhu-Chering Huang 3, Ping-Ing Lee 5, Po-Ren Hsueh 6 7 Abstract Introduction: To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical […]
Anticoagulation in COVID-19: current concepts and controversies
Authors: http://orcid.org/0000-0002-3809-8926Atanu Chandra1, 6289Uddalak Chakraborty2, Shrestha Ghosh1, Sugata Dasgupta3 Abstract Rising incidence of thromboembolism secondary to COVID-19 has become a global concern, with several surveys reporting increased mortality rates. Thrombogenic potential of the […]